Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature ; day:28 ; month:9 ; year:2023 ; pages:1-9
Current rheumatology reports ; (28.9.2023), 1-9
- Urheber
-
Vermeer, Eva
Hebing, Renske C. F.
Meeberg, Maartje M. van de
Lin, Marry
Meij, Tim G. J. de
Struys, Eduard A.
Jansen, Gerrit
Nurmohamed, Michael T.
Ćalasan, Maja Bulatović
Jonge, Robert de
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11926-023-01116-7
- URN
-
urn:nbn:de:101:1-2023121515571781076390
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vermeer, Eva
- Hebing, Renske C. F.
- Meeberg, Maartje M. van de
- Lin, Marry
- Meij, Tim G. J. de
- Struys, Eduard A.
- Jansen, Gerrit
- Nurmohamed, Michael T.
- Ćalasan, Maja Bulatović
- Jonge, Robert de
- SpringerLink (Online service)
Ähnliche Objekte (12)
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Procedural pain and patient-reported side effects with weekly injections of subcutaneous Methotrexate in children with rheumatic disorders
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
Maintenance therapy with subcutaneous immunoglobulin in a patient with immune‐mediated neuropathic postural tachycardia syndrome
Neurodevelopmental disorders: 2021 update
Neurodevelopmental disorders: 2023 update
Neurodevelopmental disorders: 2024 update
Neurodevelopmental disorders: 2022 update
Early Development of the Gut Microbiome and Immune-Mediated Childhood Disorders
Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Procedural pain and patient-reported side effects with weekly injections of subcutaneous Methotrexate in children with rheumatic disorders
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
Maintenance therapy with subcutaneous immunoglobulin in a patient with immune‐mediated neuropathic postural tachycardia syndrome
Neurodevelopmental disorders: 2021 update
Neurodevelopmental disorders: 2023 update
Neurodevelopmental disorders: 2024 update
Neurodevelopmental disorders: 2022 update
Early Development of the Gut Microbiome and Immune-Mediated Childhood Disorders
Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Procedural pain and patient-reported side effects with weekly injections of subcutaneous Methotrexate in children with rheumatic disorders
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
Maintenance therapy with subcutaneous immunoglobulin in a patient with immune‐mediated neuropathic postural tachycardia syndrome
Neurodevelopmental disorders: 2021 update
Neurodevelopmental disorders: 2023 update
Neurodevelopmental disorders: 2024 update
Neurodevelopmental disorders: 2022 update
Early Development of the Gut Microbiome and Immune-Mediated Childhood Disorders